MAKANA THERAPEUTICS, INC.

KING & SPALDING LLP representing MAKANA THERAPEUTICS, INC. · 2TY 2026 · — · view on lda.senate.gov ↗

Issues lobbied

No itemized activities in this filing.

Key facts

Filing UUID: 7cad92b3-6aea-4908-9f80-6b62bdba13f5
Filing type: 2TY
Filing period: second_quarter
Filing year: 2026
Posted: 2026-05-11T12:24:30-04:00
Registrant (lobbyist): KING & SPALDING LLP
Client: MAKANA THERAPEUTICS, INC.
Client location: FL / US
Client description: Biotechnology company
Income reported: —
Expenses reported: —